Therapeuticsmd, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
TherapeuticsMD, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, outlining key proposals including director elections, executive compensation, auditor ratification, and an increase in authorized common stock.
NASDAQ
TherapeuticsMD, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, to vote on director elections, executive compensation, auditor ratification, and a significant increase in authorized common stock.
NASDAQ
TherapeuticsMD, Inc. will hold its annual meeting of stockholders on December 5, 2024, to elect directors, approve executive compensation, and ratify the appointment of an independent auditor.
NASDAQ
TherapeuticsMD, Inc. will hold its annual meeting of stockholders virtually on December 5, 2024, to elect directors, approve executive compensation, and ratify the appointment of an independent auditor.